Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

December 23, 2022

Study Completion Date

December 23, 2022

Conditions

Opioid Overdose

Interventions

DRUG

Nalmefene HCl injection

Nalmefene Hydrochloride injection 1.5 mg for intramuscular (IM) administration

DRUG

Naloxone HCl intranasal

Naloxone 4 mg for intranasal (IN) administration

Trial Locations (1)

Ohio Clinical Trials, Columbus

All Listed Sponsors

lead

Purdue Pharma LP

INDUSTRY